Afficher la notice abrégée

dc.creatorGoulis, I.en
dc.creatorAkriviadis, E.en
dc.creatorKaratapanis, S.en
dc.creatorDeutsch, M.en
dc.creatorDalekos, G.en
dc.creatorRaptopoulou-Gigi, M.en
dc.creatorMimidis, K.en
dc.creatorGermanidis, G.en
dc.creatorTriantos, C.en
dc.creatorDrakoulis, C.en
dc.creatorChounta, A.en
dc.creatorTsoplou, F.en
dc.creatorZintzaras, E.en
dc.creatorBakalos, G.en
dc.creatorPapatheodoridis, G.en
dc.date.accessioned2015-11-23T10:28:50Z
dc.date.available2015-11-23T10:28:50Z
dc.date.issued2012
dc.identifier.issn0168-8278
dc.identifier.urihttp://hdl.handle.net/11615/28105
dc.source.uri<Go to ISI>://WOS:000303241301071
dc.subjectGastroenterology & Hepatologyen
dc.titleHBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A 40KD (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSISen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée